Amodaia logo with green abstract symbol and white text on a light background | Amodaia
×

Case Studies

How We Deliver Results

From preclinical biotech to commercial medtech and investor storytelling, our clients trust us to deliver clarity, compliance, and outcomes – without the delays, handoffs, or compromises of larger agencies.

Below are anonymised and country-tagged success stories showing the speed, quality, and strategic impact we deliver across regulatory, medical affairs, market access, fundraising, and medcomms.

Case Studies

Across regulatory writing, medical strategy, safety reporting, and commercial content.

Biotech | Switzerland – Regulatory Writing & Dual-Agency Submission Support

Challenge: Parallel EMA and FDA submissions under compressed timelines required alignment across regulatory, clinical, and CMC teams.

Solution: Defined the regulatory strategy and aligned cross-functional documentation into a coherent submission narrative.

Impact: Submission-ready dossiers delivered on time with reduced review cycles and stronger regulatory alignment.

Biotech | EU – Medical Affairs for Launch Readiness

Challenge: Fragmented scientific messaging across publications, field materials, and launch activities.
Solution: Developed a unified scientific narrative across publications, HCP materials, and internal communications.
Impact: Consistent scientific positioning, streamlined reviews, and stronger launch readiness.

Biotech | EU – Market Access Payer Readiness for TED Biologic

Challenge: HEOR evidence and value messaging lacked alignment for regional payer engagement.

Solution: Built a coherent value framework aligning clinical, economic, and payer evidence.

Impact: Stronger payer positioning and greater confidence during HTA and reimbursement discussions.

Medtech | United Kingdom – Marketing Communications for Oncology Diagnostic Launch

Challenge: A new oncology diagnostic required a clear and differentiated launch narrative.
Solution: Created evidence-based messaging and MLR-ready launch materials across multiple channels.
Impact: Faster stakeholder engagement, smoother reviews, and a consistent commercial narrative.

Biotech | United States – Fundraising & Investor Relations Narrative and Outreach

Challenge: Strong science lacked a compelling investment narrative ahead of a fundraising round.
Solution: Developed the investment story, investor materials, outreach strategy, and supported investor engagement.
Impact: A stronger investment proposition, more focused investor discussions, and improved fundraising readiness. 

Contact Details

Connect With Us

Contact Form

You need to fill up this field
You need to provide valid email address
You need to fill up this field
You need to fill up this text field
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thank you for contacting us. One of our colleagues will get in touch with you soon.

Okay